Shareholders' Equity (Tables)

12 Months Ended

Oct. 31, 2015

Shareholders' Equity [Abstract]

Schedule of Stock Option Activity

	For the Year ended
	October 31, 2015			October 31, 2014
		Weighted			Weighted
		Average			Average
		Exercise			Exercise
	Shares	Price		Shares	Price
Outstanding at beginning of period	52,650	$	7.01	110,370	$	6.83
Granted	150,000		6.07	22,500		9.12
Exercised	(11,137)		5.13	(865)		6.60
Expired or cancelled	(13,613)		5.16	(79,355)		7.37
Outstanding at end of period	177,900	$	6.48	52,650	$	7.01

Schedule of Stock Options Outstanding

		Weighted
		Average
		Remaining	Number
	Number	Contractual	Subject to
Exercise Prices	Outstanding	Life	Exercise
$6.07	150,000	6.58	—
6.76	5,400	7.03	3,598
9.12	22,500	5.59	7,499
Total	177,900	6.47	11,097

Schedule of Stock Option Valuation Assumptions

	Options Granted	Options Granted
	May 28, 2015	June 1, 2014
Weighted average fair value of options granted	$3.27	$5.17
Assumptions used:
Expected life (years)	7.00	7.00
Risk-free interest rate	1.25%	1.70%
Volatility	53.11%	55.78%
Dividend Yield	0.00%	0.00%

a) Expected life:  For employee grants, the expected term of options granted is determined using historical data, the contractual terms of the options granted and other factors.

b) Risk-free interest rate:  The rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected life of the options.

c) Volatility:  The expected volatility of the Company’s common stock is calculated by using the historical daily volatility of the Company’s stock price calculated over a period of time representative of the expected life of the options.

d) Dividend yield:  The dividend yield rate is not considered in the model, as the Company has not established a dividend policy for the stock and, other than the one-time special dividend the Company paid in April 2013, the Company has not historically paid any dividends.

Schedule of Restricted Stock Activity

	For the Year ended
	October 31, 2015			October 31, 2014
		Weighted			Weighted
		Average			Average
		Grant Date			Grant Date
	Shares	Fair Value		Shares	Fair Value
Unvested at beginning of period	57,035	$	8.40	66,094	$	5.88
Granted	31,261		7.03	37,725		9.68
Vested	(38,303)		8.32	(46,784)		5.87
Unvested at end of period	49,993	$	7.61	57,035	$	8.40

Schedule of Pre-Tax Stock-Based Compensation Expense Recognized

	Year ended October 31,
(In thousands)	2015		2014
Cost of revenues	$	4	$	5
Selling and marketing		97		81
General and administrative		389		348
Research and development		6		7
Stock-based compensation expense	$	496	$	441